openPR Logo
Press release

In-vitro Fertilization Devices Market Growth Factors 2018–2026 | Key Players are Vitrolife AB, CooperSurgical Inc., Thermo Fisher Scientific Inc., COOK MEDICAL INC., Genea Biomedx, Merck KGaA, OvaScience

12-26-2018 07:20 AM CET | Health & Medicine

Press release from: Coherent Market Insights - Medical Devices

In-vitro Fertilization Devices

In-vitro Fertilization Devices

In-vitro fertilization (IVF) is the most effective form of assisted reproductive technology (ART) associated with treatment of infertility and genetic disorders related to child conception. According to the Centers for Disease Control and Prevention (CDC), in 2015, 231,936 ART cycles were performed in 464 reporting clinics in the U.S., resulting in 60,778 live births. The ART cycle consist of series of process, including ART procedure, followed by ovarian stimulation and unfreezing of embryos for transfer into the uterus. Maternal age, reproductive history, embryo status while transfer, cause of infertility, lifestyle factors such as smoking, obesity, and use of alcohol, drugs, and excessive caffeine are factors that need to be taken into account before undergoing the IVF procedure, as they are responsible for determining the success of IVF. Infertility associated with female and male partners was found to be a major driver fueling growth of the in-vitro fertilization devices market. According to the National Survey of Family Growth conducted between 2011 and 2013, around 61 million women belonging to the age group of 15- 44 years underwent a medical test to diagnose infertility, at some phase in their lives. Additionally, 6% of these women were unable to conceive even after 12 months of consistent efforts to conceive.

Download PDF Brochure of This Business Research Report@ https://www.coherentmarketinsights.com/insight/request-pdf/887

Certain risks are associated with in-vitro fertilization procedures such as premature delivery, low birth weight, multiple births, ovarian hyperstimulation syndrome, and complications associated with egg retrieval procedures, miscarriage, birth defects, ectopic pregnancy, and ovarian cancer. These risks pose as major factors limiting growth of the in-vitro fertilization devices market. According to the CDC’s 2015 Fertility Clinic Success Rates Report, around 1.6% of all infants born in the U.S., were conceived by using assisted reproductive technology.

As of 2017, around 6.7% of married women between 15 and 44 years of age, are estimated to be infertile and 12.1% are estimated to be suffering from impaired fecundity in the U.S., according to CDC. Furthermore, obesity, cigarette smoking, and binge drinking makes men and women more susceptible to the risk of infertility. The increasing numbers of the women of reproductive age in U.S., have chronic conditions and related risk factors, which includes obesity, smoking and drinking, that can affect overall health, future fertility, pregnancy and birth outcome. According to Behavioral Risk Factor Surveillance System Data by CDC, in 2014, women belonging to the age range of 18 to 44 years, in the U.S. were reported to be obese (52.8%), which is a major cause in infertility, followed by those involves in cigarette smoking (19.2%) and binge drinking (16.9%).

The American Society for Reproductive Medicine (ASRM), reported that the average cost of an IVF cycle in the U.S. is around US$ 12,400, which includes fertility medications, preliminary test, ultrasound monitoring, and blood tests. However, number of IVF cycles required depends upon the patient’s age and quality of the embryo and semen. Furthermore, depending on patient’s circumstance, the demand for ART treatment such as Intra Cytoplasmic Sperm Injection (ICSI) is expected to increase, in turn, increasing the costs associated with in-vitro fertilization by US$ 1,000 to US$ 3,000. Thus, the overall treatment methods make in-vitro fertilization expensive, in turn, restraining growth of the in-vitro fertilization devices market.

Key players operating in in-vitro fertilization devices market include Vitrolife AB, CooperSurgical Inc., Thermo Fisher Scientific Inc., COOK MEDICAL INC., Genea Biomedx, Merck KGaA, OvaScience, Inc., JXTG Holdings, Inc., Progyny, Inc., and Oxford Gene Technology Inc., EMD Serono,Inc., and Irvine Scientific.

Request For Customization Of This Business Research Report@ https://www.coherentmarketinsights.com/insight/request-customization/887

In-vitro Fertilization Devices Market Taxonomy:

By product type

Incubator
IVF consumables
Cultural media
Inverted microscope
Laminar air flow instrument
Embryo freezers
Embryo cryogenic storage tank

By end user

Hospitals
Gynecological clinics
IVF center
Clinical research institutes

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In-vitro Fertilization Devices Market Growth Factors 2018–2026 | Key Players are Vitrolife AB, CooperSurgical Inc., Thermo Fisher Scientific Inc., COOK MEDICAL INC., Genea Biomedx, Merck KGaA, OvaScience here

News-ID: 1459338 • Views: 709

More Releases from Coherent Market Insights - Medical Devices

Gamma Knife Market: Region Wise Analysis of Top Players in Market by its Types and Application 2018-2026
Gamma Knife Market: Region Wise Analysis of Top Players in Market by its Types a …
The global gamma knife market was valued at US$ 174.4 million in 2016 and is expected to expand at a CAGR of 7.7% during the forecast period (2017 – 2025). Chronic neurological disorders such as metastatic brain tumors, trigeminal neuralgia, and arteriovenous malformations are complex to treat. Standard brain surgery and radiation therapy can damage healthy tissues and cause various side effects. Moreover, these treatment methods involve in-hospital post treatment
Fetal Monitoring Market By Worldwide Analysis, Estimation, Industry Applications, Key Growths with Leading players like - ArjoHuntleigh, Inc. (U.S.), C FUJIFILM SonoSite,
Fetal Monitoring Market By Worldwide Analysis, Estimation, Industry Applications …
Fetal monitoring devices are used to monitor the heart rate and movement of the fetus and maternal contractions. In medical terms, fetal monitoring is imperative to constantly monitor health of the unborn baby and ensure a safe birth. Fetal monitoring measures the heart rate of the baby. Healthcare providers perform fetal monitoring during late pregnancy and labor, as that process is crucial for keeping the mother and the child safe
Global Continuous Glucose Monitoring (CGM) Market Includes Latest Key Development and Market Dynamics Appraised By Global Players Abbott Laboratories, Roche Diagnostics, Dexcom Inc., Bayer AG, Medtronic, Inc
Global Continuous Glucose Monitoring (CGM) Market Includes Latest Key Developmen …
Diabetes is a major global concern that, as per International Diabetes Federation (IDF) data, affected around 415 million people in 2015. Effective management of diabetes is vital, especially considering the sedentary lifestyle that most people across the globe have taken up. Continuous glucose monitoring (CGM) systems offer effective solution in diabetes management through continuous real-time glucose monitoring. Increasing awareness, supporting safety evidences for CGM systems and growing demand for point-of-care
Insulin Pumps Market Report 2018-2026 Focuses On Top Companies Medtronics, Braun Melsungen Abbott Laboratories, Becton, Dickinson and Company, Sanofi, Insulet Corporation
Insulin Pumps Market Report 2018-2026 Focuses On Top Companies Medtronics, Braun …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin

All 5 Releases


More Releases for IVF

IVF Devices and Consumables Market Size To Reach USD 7.73 Billion, Globally, By …
In vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the widely used treatments, which assists couples with infertility problems, single mothers, and the LGBT community to procreate. Increase in infertility rate, rise in awareness toward IVF, growth in demand for advanced IVF technologies, and surge in IVF success
IVF Services Market size is Generating Revenue of $25.6 Billion by 2026 | Fresh …
In vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the widely used treatments, which assists couples with infertility problems and single mothers & the LGBT community to procreate. Increase in infertility rate, rise in trend of delayed pregnancies, surge in IVF success rate, and upsurge in disposable income
How In Vitro Fertilization Market Will Dominate In Coming Years? Key Players: Mo …
The global in vitro fertilization (IVF) market size is prophesized to reach USD 36.39 billion by 2026, with a CAGR 10.1% by 2026. This is attributable to the increasing cases of infertility among people worldwide. This is more common in males than female partners. The market value was USD 16.89 billion in 2018. IVF is a fertilization process wherein sperm and eggs are retrieved as a sample and are combined
Growth Dynamics on In Vitro Fertilization Market 2020-2026| Key Players: Monash …
The global in vitro fertilization (IVF) market size is prophesized to reach USD 36.39 billion by 2026, with a CAGR 10.1% by 2026. This is attributable to the increasing cases of infertility among people worldwide. This is more common in males than female partners. The market value was USD 16.89 billion in 2018. IVF is a fertilization process wherein sperm and eggs are retrieved as a sample and are combined
How In Vitro Fertilization Market Will Dominate In Coming Years? Key Players: Mo …
The global in vitro fertilization (IVF) market size is prophesized to reach USD 36.39 billion by 2026, with a CAGR 10.1% by 2026. This is attributable to the increasing cases of infertility among people worldwide. This is more common in males than female partners. The market value was USD 16.89 billion in 2018. IVF is a fertilization process wherein sperm and eggs are retrieved as a sample and are combined
Growth Dynamics on In Vitro Fertilization Market 2020-2026| Key Players: Monash …
The global in vitro fertilization (IVF) market size is prophesized to reach USD 36.39 billion by 2026, with a CAGR 10.1% by 2026. This is attributable to the increasing cases of infertility among people worldwide. This is more common in males than female partners. The market value was USD 16.89 billion in 2018. IVF is a fertilization process wherein sperm and eggs are retrieved as a sample and are combined